Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02607813 |
|---|---|
| Brief Title: | Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations |
| First Submitted : | November 5, 2015 |
| First Submitted that Met QC Criteria : | November 17, 2015 |
| First Posted : | November 18, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 20, 2022 |
| Last Update Posted : | December 21, 2022 |